Showing 46 to 60 of 417 results
HCPC welcomes PSA publication: “Ethics in extraordinary times: practitioner experiences during the Covid-19 pandemic”
This report explores the ethical experiences of practitioners working in health and social care professions and was commissioned by the Authority from Professor Deborah Bowman.
August bank holiday 2024 service availability
The HCPC offices will be closed on Monday 26 August for the summer bank holiday weekend
Key findings from the Year in Registration Survey 2023
Key findings from our year in registration survey, which aims to gather insight about how students’ education and training prepares them for practice.
Update on the Indicative Sanctions Policy review
In early 2017, the HCPC commenced a review of the Indicative Sanctions Policy to ensure it is up to date, reflects public opinion, and continues to support fair and proportionate decision making. As part of this review we commissioned market research into the public’s views of the Policy and undertook a public consultation.
The two criteria for choosing CPD
Continuing professional development (CPD) should improve your work and have a positive impact for your service users
We have revised our standards for prescribing
The Health and Care Professions Council has recently revised our standards for prescribing, following a public consultation. The revised standards took effect on 1 September 2019.
Winners of the HCPC student competition 2023 announced
Find out who won the HCPC student competition 2023, which asked students to design a learning session about health and wellbeing.
Launch date announced for specialist social work regulator
Nadhim Zahawi has announced Monday 2 December 2019 as the date when Social Work England will take over from the HCPC as the new social work regulator
HCPC statement on guidance on health and character and suicidal ideation
Our priority is ensuring that registrants have access to advice and support, so that they can get the help they need and ensure they are able to continue to practise safely, without fear of the impact on their registration. To support this, we have produced online materials aimed at registrants and updated our guidance on health and character to include more illustrative case studies.
Reclassification of Gabapentin and Pregabalin
From midnight on 1st April 2019, gabapentin and pregabalin will be reclassified as Schedule 3 controlled drugs, under the Misuse of Drugs Regulations (2001), and Class C of the Misuse of Drugs Act (1971)
Call-out for working group members following consultation closure
The HCPC consultation on the Standards of conduct, performance and ethics, and accompanying guidance on social media closed on 16 June 2023.